SlideShare a Scribd company logo
By: Solmaz J
Locked-in Syndrome
The states of coma and the vegetative state must be distinguished from a syndrome in which
there is little or no disturbance of consciousness, but only an inability of the patient to respond adequately.
The latter is referred to as the locked-in syndrome or the deefferented state.
The locked-in syndrome is most often caused by a lesion of the ventral pons (basis pontis) as a result of occlusion
of the basilar artery. Such an infarction spares both the somatosensory pathways, and the ascending neuronal
systems responsible for arousal and wakefulness, as well as certain midbrain elements that allow the eyelids to be
raised in wakefulness; the lesion essentially interrupts the corticobulbar and corticospinal pathways, depriving the
patient of speech and the capacity to respond in any way except by vertical gaze and blinking.
Severe motor neuropathy (e.g., Guillain-Barre syndrome), pontine myelinolysis, or periodic paralysis may have a
similar effect.
Acute peripheral neuropathy
Acute peripheral neuropathy
SYNDROME OF ACUTE MOTOR PA RALYS IS
WITH VA RIABLE DISTURBANCE OF
SENSORY AND AUTONOMIC FUNCTION
A number of differences separate the polyneuropathies
in this category:
(1) acute inflammatory demyelinating or axonal polyneuropathy (GBS)
(2) vasculitic polyneuropathies
(3) porphyria
(4) certain toxic polyneuropathies
(5) acute sensory and autonomic polyneuropathies
Of these various acute polyneuropathic diseases, the
Guillain-Barre demyelinative syndrome, because of its
frequency and gravity, is most demanding of the physi
cian's attention
CASE
• A 15 yr old male,came to ED with complaints of pain in the calf of
the right leg on Tuesday(1week ago),followed by weakness of the
both lower limbs the next day morning.was bed ridden after the
onset of weakness.his bowel and bladder are intact.he is able to
feel sensation of clothes over the lower limbs.he felt heaviness of
the limbs..taken to local hospital was given treatment..where he
noticed weakness in the upper limbs also.
• no symptoms of cranial nerve involvement.
• no hx fever at the onset of weakness.
• no hx recent immunization or no h/o dog bite.
• no hx seizures episodes.
• no hx similar complaints in the past.
• no hx similar complaints in the family.
Clinical examination
• Patient was consciuos coherent
• no pallor ,icterus,clubbing,lymphadenopathy,edema.
• His BP is 110/70 mm Hg in supine,100/70 mm Hg on standing.no postural
hypotension.
• Pulse -82/min regular,all peripheral pulses felt.
• Respiratory rate -18 /min.breath holding time –able to count upto 45 in single
breath.
NERVOUS SYSTEM
• Higher intellectual functions intact
• Cranial nerves normal
• Motor system showed hypotonia of all four limbs.
• Grade 3/5 in upperlimbs,2/5 across the hip joint,knee joint,o/5 power across
ankle joint.
• Hyporeflexia all DTRs,absent ankle
• Babinski negative,abdominal present
• Sensory intact
• Gait –stance …
• Other systems normal.
Key points
• Rapid progressive ascending paralysis.
• Acute onset
• Motor paralysis
• Intact sensory
• No cranial nerve involvement
• No bladder involvement
• No fever at onset of weakness
• Diagnosis………………??????????????????
Acute peripheral neuropathy
OTHER NAMES
• LANDRY’S ASCENDING PARALYSIS
• ACUTE INFLAMMATORY DEMYELINATING POLYNEUROPATHY (AIDP)
• ACUTE IDIOPATHIC POLYRADICULONEURITIS
• ACUTE IDIOPATHIC POLYNEURITIS
• FRENCH POLIO
• LANDRY GUILLAIN BARRE SYNDROME
INTRODUCTION
Acute,frequently severe and
fulminant polyradiculoneuropathy
that is autoimmune in nature.
Antecedent events (causes)
• 70% cases –post infectious .
• 1-3 weeks after an acute infectious process respiratory or GIT.
• 20-30% cases –campylobacter jejuni
• Other agents –HHV (EBV,CMV)
• Mycoplasma pneumoniae
• Recent immunisation –swine influenza vaccine,older rabies vaccine
(nervous system)
• Can be seen in patients with lymphoma,HIV positive,SLE.
AIDP
• Adults > children
• Rapid recovery
• Anti GM1 ab (50%)
• Demyelinating
• First attack on schwann cell surface
• Widespread myelin damage
• Lymphocyte infiltration
• Variable sec axonal damage
Acute peripheral neuropathy
AMAN (ACUTE MOTOR AXONAL
NEUROPATHY)
Acute motor axonal neuropathy (AMAN) is a variant of Guillain-Barré syndrome. It is characterized by
acute paralysis and loss of reflexes without sensory loss.
The syndrome typically presents as a progressive flaccid symmetric paralysis with areflexia, often causing
respiratory failure
• Children ,young adults
• Seasonal
• Recovery rapid
• Anti GD1 a ab
• Axonal
• First attack on motor nodes of ranvier
• Macrophage activation
• Axonal damage is variable
MILLER FISCHER VARIANT
• Adults,children
• Uncommon
• Anti GQ 1 b anitbodies >90%
(Not seen in other forms of GBS
Unless there is EOM invovlement)
• Pupillary paralysis
Clinical manifestations
FEVER AND CONSTITUTIONAL SYMPTOMS ARE ABSENT AT THE ONSET
MOTOR SYSTEM :
• Rapidly evolving areflexic motor paralysis with or without sensory disturbance.
• Ascending type of paralysis
• RUBBERY LEGS.
• Weakness evolves over hours –days.
• Legs>arms
DEEPTENDON REFLEXES:
Reflexes attenuate,disappear in few days of onset.
Acute peripheral neuropathy
CRANIAL NERVES:
Facial diparesis seen in 50% affected individuals.
Lower cranial nerves affected –bulbar weakness – difficulty in handling
secretions,maintaining airway.
Ophthalmoplegia –miller fischer variant
Pupillary paralysis
Optic atrophy
SENSORY SYSTEM:
Largely myelinated fibres are severely affected.
Proprioception is more affected than pain temperature sensation.
BLADDER:
Only in severe cases,transiently.
If bladder dysfunction is a prominent feature and comes early in the course,think
other than GBS – spinal cord disease.
• PAIN:
• Deep aching pain may be present the previous day in
weakened muscles.
• Initially at onset –neck,shoulder,back,diffusely over spine -50%
cases.
• Dysesthetic pain in extremities
• Self limited usually
• Responds to analgesics
• AUTONOMIC INVOLVEMENT:
• Common
• Seen even in mild cases
• Wide fluctuation in blood pressure
• Postural hypotension
• Cardiac dysrryhthmias
• Close monitoring and management
• Can be fatal.
• All require hospitalisation
• 30% require ventilatory support
course
• Pattern of rapidly progressive
(evolving) paralysis with areflexia
• Usually does not progress beyond four weeks after reaching a
plateau.
Lab features
CSF :
• Raised CSF protein 1-10 g/l (100-1000mg/dl)
• Without accompanied by pleocytosis
• Usually normal in <1week
• Increased proteins at the end of first week
• 10-100/ul elevation
• Think of HIV ,CMV in case of pleocytosis.
ELECTRODIAGNOSTIC TESTS:
May be normal
Lags behind clinical events
demyelination - prolonged distal latencies,conduction velocity slowing,condcution block.
Reduced amplitude of compound action potential without conduction slowing
Criteria for diagnosis
REQUIRED :
• 1.progressive weakness of 2 or more limbs due to neuropathy.
• 2.areflexia
• 3.disease course < 4 weeks
• 4 exclusion of other causes (vasculitis,PAN,SLE,churg strauss
syndrome,toxins,lead,botulism,diptheria,porphyria.,cauda equinal
syndrome)
SUPPORTIVE:
• 1.relatively symmetric weakness
• 2.mild sensory involvement
• 3.facial nerve or other cranial nerve involvement
• 4.absence of fever
• 5.typical CSF profile(aceelualr,increase in protein level)
• 6.electrophysiologic evidence of demyelination
treatment
• Initiate as soon as possible.
• Each day counts
• 2 weeks after the first motor symptoms – immunotherapy is no longer effective.
• IVIg
• Plasmapheresis
• Combination is not effective
• IVIg-first choice,easy to administer
• Five daily infusions 2g/kg body weight
• Plasmapheresis 40-50ml/kg four times a week
• Treatment reduces need for ventilation by half.,increases full recovery at an year.
• Glucocorticoids are not effective in GBS.
• Conservative management in mild cases.
 This type of polyneuropathy appears after several days or more of bacterial sepsis or other
overwhelming infection (now called systemic inflammatory response syndrome
[SIRS]) and multiple organ failure, and is preceded in most instances by a confusional state or a
depressed state of consciousness ("septic encephalopathy").
 The neuropathic process, predominantly of motor type, varies in severity from an
electrophysiological abnormality without overt clinical signs, to quadriparesis with respiratory
failure.
 Sensory symptoms and signs are variable but tend to be mild. Usually the cranial nerves are
spared and there are few or no dysautonomic manifestations.
In general,
 The EMG and NCS findings of a primary axonal process with early denervation and a normal
CSF distinguish this entity from the typical demyelinative form of GBS.
Critical Illness Polyneuropathy
Local action of the exotoxin may paralyze pharyngeal and laryngeal
muscles (dysphagia, nasal voice) within 1 or 2 weeks after the onset
ofthe infection and shortly thereafter may cause blurring of vision
because of paralysis of accommodation, but these and other cranial
nerve symptoms may be overlooked. At this stage, the cranial
neuropathy must be distinguished from that of GBS, botulism, and most
of all, from myasthenia gravis.
A polyneuropathy, appearing 5 to 8 weeks later, takes the form of an
acute or subacute limb weakness with paresthesias and distal loss of
vibratory and position sense.
The weakness characteristically involves all extremities at the same time
or may descend from arms to legs. The patient may be unable to stand
or walk and occasionally the paralysis is so extensive as to impair
respiration. The CSF protein is usually elevated (50 to 200 mg/dL) .
The important pathologic change is one of segmental demyelination
without inflammatory reaction of spinal roots, sensory ganglia, and
adjacent spinal nerves.Anterior hom cells, axons, peripheral nerves
Diphthertic Polyneuropathy
• Treatment
Diphtheria antitoxin, given within 48 h of the onset of the infection,
Antitoxin is probably of little value once the polyneuropathy
begins.Thereafter, treatment is purely symptomatic, along the lines
indicated for GBS.
Acute porphyria
Acute porphyrias include forms of the
disease that typically cause nervous
system symptoms which appear quickly
and can be life threatening.
Acute porphyria attacks are rare be for
puberty and after menopause in women.
symptom may last one to two weeks and
usually improve slowly after the attack.
Possible sign and symptoms:
severe abdominal pain
swelling of the abdomen (abdominal distention)
pain in your chest,legs or back
constipation or diarrhea
vomiting
insomnia
 heart beat you can feel (palpitation)
high blood pressure
anxiety or restlessness
seizures
mental change ,such as confusion,hallucination,disorientation or paranoia
breathing problems
muscle pain ,tingling,numbness,weakness or paralysis
red or brown urine
stopping medications that may have triggered symptoms
medication to control pain,nausea and vomiting
prompt treatment of infections or other illness that may have
caused symptoms
intravenous sugar(glucose) or sugar taken by mouth,if able
maintain an adequate intake of carbohydrates
intravenous fluids to combat dehydration
injection of hemin,a medication that is a form of heme , to
limit the body's production of porphyrin
the peripheral nerves may be affected by a wide variety of toxins
including metals, drugs, organophosphates, and industrial solvents.
As a rule, the neuropathies induced by these agents fall into the
subacute and chronic categories.
However, certain drugs-notably
triorthocresyl phosphate (TOCP) and other organophosphates ,
thallium
and rarely, arsenic
produce a polyneuropathy that may be fatal in a matter of days.
Acute Toxic Polyneuropathies
Severe and permanent motor paralysis is caused by TOCP; this ultimately proves to be a result of involvement
of both upper and lower motor neurons.
Some cases of arsenical and possibly mercurial polyneuropathy may also develop acutely.
Thallium salts
when taken in sufficient amount, produce a clinical picture resembling that of GBS or an acute
sensory polyneuropathy.
If the salts are taken orally,there is first abdominal pain, vomiting, and diarrhea, followed within a
few days by pain and tingling in the toes and fingertips and then rapid weakening of muscles of
the limbs, initially the distal ones.
As the weakness progresses, the tendon reflexes diminish.
Pain sensation is reduced more than tactile, vibratory; and position sense.
Persistent acral pain with allodynia has been a major feature in 3 of the 5 patients we have
examined; in 2 of our patients there was no weakness, only sensory loss and ataxia.
All cranial nerves except the first and eighth may be affected;
facial palsies, ophthalmoplegia, nystagmus, optic neuritis with visual impairment, and vocal cord
palsies are additional abnormalities but only in the most severely affected patients.
The CSF protein rises to more than 100 mg. Death may occur in the first 10 days as a result of
cardiac arrest.
The early onset of painful paresthesias, sensory loss, and pain localized to joints, back, and chest,
as well as rapid loss of hair (after a week or two), all serve to differentiate this neuropathy from
GBS,porphyria, and other acute polyneuropathies.
Thallium salts act like potassium and a high intake of potassium chloride hastens the excretion of
thallium. Chelating agents are of unproven value but are usually included in treatment.
On occasion, a vasculitic polyneuropathy as an isolated process or
associated with lupus erythematosus, polyarteritis nodosa, and related
disorders may develop as rapidly as GBS. Three of our patients with
polyarteritis and one with Churg-Strauss disease became completely
paralyzed within a week and one died of intestinal perforation.
We have observed a few patients with alcoholism,occult carcinoma,
Hodgkin disease, and renal transplantation develop an acute
polyneuropathy, as rapid in its evolution as GBS, and acute episodes of
this type have also been described in patients with Refsum disease.
Other Acute Polyneuropathies
Acute peripheral neuropathy

More Related Content

PPTX
Approach to dystonia
PPTX
PPTX
Hirayama Disease.pptx
PPTX
POLYSOMNOGRAPHY & EEG ACTIVATION METHODS
PPTX
cerebellar dysfunction-ppt
PPTX
Congenital myasthenic syndrome
PPTX
EEG Epilepsy
PPTX
Multiple sclerosis
Approach to dystonia
Hirayama Disease.pptx
POLYSOMNOGRAPHY & EEG ACTIVATION METHODS
cerebellar dysfunction-ppt
Congenital myasthenic syndrome
EEG Epilepsy
Multiple sclerosis

What's hot (20)

PPTX
PPTX
Motor Neuron Disease
PPTX
Motor neuron disease - Etiology, Pathogenesis, Clinical Features, Classificat...
PPTX
Motor neuron diseases
PPTX
Ape thumb deformity to publish
PPTX
Hereditary motor and sensory neuropathy
PPT
Myasthenia gravis
PPTX
Myopathies
PPT
Repetitive Nerve Stimulation (RNS)
PPTX
Electrodiagnostic approach to peripheral neuropathy
DOC
Superficial reflexes
PPTX
EEG in idiopathic generalised epilepsies
PPTX
Brunnstrom's hand recovery stages
PPTX
Variants of AIDP & CIDP.pptx
PPT
Neurobiology of pain
PPTX
Periodic lateralized epileptiform discharges
PPTX
Ataxia
PDF
Guillain Barre syndrome (GBS) .pdf
PPT
Spinal muscle atrophy
PPSX
Cerebellar ataxia
Motor Neuron Disease
Motor neuron disease - Etiology, Pathogenesis, Clinical Features, Classificat...
Motor neuron diseases
Ape thumb deformity to publish
Hereditary motor and sensory neuropathy
Myasthenia gravis
Myopathies
Repetitive Nerve Stimulation (RNS)
Electrodiagnostic approach to peripheral neuropathy
Superficial reflexes
EEG in idiopathic generalised epilepsies
Brunnstrom's hand recovery stages
Variants of AIDP & CIDP.pptx
Neurobiology of pain
Periodic lateralized epileptiform discharges
Ataxia
Guillain Barre syndrome (GBS) .pdf
Spinal muscle atrophy
Cerebellar ataxia
Ad

Similar to Acute peripheral neuropathy (20)

PPTX
GBS.pptx
PPT
Neuromuscular disorders in icu
PPTX
Gullain_Barre_Syndrome_)_BY_FZ.pptx
PPTX
Bdak2 epilepsy
PPTX
Seizure and Epilepsy Seizure and Epilepsy (2).pptx
PPTX
epilepsy management.powerpoint presentation
PDF
Dr Aman ppt - Copyy.pdf
PPTX
Epileptiform disorders Classification.pptx
PPTX
Epilepsy Clinical Features, Pathophysiology & Management.pptx
PPTX
Epilepsy in children by dr. cirelda Gomez.pptx
PPTX
PPTX
dr medina............................pptx
PPTX
Fantastic facial movements and where to find them 111118
PPTX
Guillain barre syndrome
PPTX
Overview of neonatal epilepsy syndromes.pptx
PPTX
Guillain-Barré Syndrome.pptx
DOCX
Neuropsychiatric aspects of epilepsy osmanali
PPTX
EPILEPSY case presentation ppt ooioiooiii
PPTX
Seizure & Epilepsy (qggakbhghfccbbjklvcf
PPTX
Epilepsy
GBS.pptx
Neuromuscular disorders in icu
Gullain_Barre_Syndrome_)_BY_FZ.pptx
Bdak2 epilepsy
Seizure and Epilepsy Seizure and Epilepsy (2).pptx
epilepsy management.powerpoint presentation
Dr Aman ppt - Copyy.pdf
Epileptiform disorders Classification.pptx
Epilepsy Clinical Features, Pathophysiology & Management.pptx
Epilepsy in children by dr. cirelda Gomez.pptx
dr medina............................pptx
Fantastic facial movements and where to find them 111118
Guillain barre syndrome
Overview of neonatal epilepsy syndromes.pptx
Guillain-Barré Syndrome.pptx
Neuropsychiatric aspects of epilepsy osmanali
EPILEPSY case presentation ppt ooioiooiii
Seizure & Epilepsy (qggakbhghfccbbjklvcf
Epilepsy
Ad

Recently uploaded (20)

PPTX
Electromyography (EMG) in Physiotherapy: Principles, Procedure & Clinical App...
PDF
Human Health And Disease hggyutgghg .pdf
PPTX
Respiratory drugs, drugs acting on the respi system
PDF
CT Anatomy for Radiotherapy.pdf eryuioooop
PPTX
neonatal infection(7392992y282939y5.pptx
PPT
Management of Acute Kidney Injury at LAUTECH
PDF
Intl J Gynecology Obste - 2021 - Melamed - FIGO International Federation o...
PPTX
Neuropathic pain.ppt treatment managment
PPTX
15.MENINGITIS AND ENCEPHALITIS-elias.pptx
PPT
Obstructive sleep apnea in orthodontics treatment
PDF
Deadly Stampede at Yaounde’s Olembe Stadium Forensic.pdf
PPTX
surgery guide for USMLE step 2-part 1.pptx
PPT
ASRH Presentation for students and teachers 2770633.ppt
PDF
NEET PG 2025 | 200 High-Yield Recall Topics Across All Subjects
PPTX
ca esophagus molecula biology detailaed molecular biology of tumors of esophagus
PPTX
ACID BASE management, base deficit correction
PPT
1b - INTRODUCTION TO EPIDEMIOLOGY (comm med).ppt
PPTX
Important Obstetric Emergency that must be recognised
PPTX
Note on Abortion.pptx for the student note
PPTX
Fundamentals of human energy transfer .pptx
Electromyography (EMG) in Physiotherapy: Principles, Procedure & Clinical App...
Human Health And Disease hggyutgghg .pdf
Respiratory drugs, drugs acting on the respi system
CT Anatomy for Radiotherapy.pdf eryuioooop
neonatal infection(7392992y282939y5.pptx
Management of Acute Kidney Injury at LAUTECH
Intl J Gynecology Obste - 2021 - Melamed - FIGO International Federation o...
Neuropathic pain.ppt treatment managment
15.MENINGITIS AND ENCEPHALITIS-elias.pptx
Obstructive sleep apnea in orthodontics treatment
Deadly Stampede at Yaounde’s Olembe Stadium Forensic.pdf
surgery guide for USMLE step 2-part 1.pptx
ASRH Presentation for students and teachers 2770633.ppt
NEET PG 2025 | 200 High-Yield Recall Topics Across All Subjects
ca esophagus molecula biology detailaed molecular biology of tumors of esophagus
ACID BASE management, base deficit correction
1b - INTRODUCTION TO EPIDEMIOLOGY (comm med).ppt
Important Obstetric Emergency that must be recognised
Note on Abortion.pptx for the student note
Fundamentals of human energy transfer .pptx

Acute peripheral neuropathy

  • 2. Locked-in Syndrome The states of coma and the vegetative state must be distinguished from a syndrome in which there is little or no disturbance of consciousness, but only an inability of the patient to respond adequately. The latter is referred to as the locked-in syndrome or the deefferented state. The locked-in syndrome is most often caused by a lesion of the ventral pons (basis pontis) as a result of occlusion of the basilar artery. Such an infarction spares both the somatosensory pathways, and the ascending neuronal systems responsible for arousal and wakefulness, as well as certain midbrain elements that allow the eyelids to be raised in wakefulness; the lesion essentially interrupts the corticobulbar and corticospinal pathways, depriving the patient of speech and the capacity to respond in any way except by vertical gaze and blinking. Severe motor neuropathy (e.g., Guillain-Barre syndrome), pontine myelinolysis, or periodic paralysis may have a similar effect.
  • 5. SYNDROME OF ACUTE MOTOR PA RALYS IS WITH VA RIABLE DISTURBANCE OF SENSORY AND AUTONOMIC FUNCTION A number of differences separate the polyneuropathies in this category: (1) acute inflammatory demyelinating or axonal polyneuropathy (GBS) (2) vasculitic polyneuropathies (3) porphyria (4) certain toxic polyneuropathies (5) acute sensory and autonomic polyneuropathies Of these various acute polyneuropathic diseases, the Guillain-Barre demyelinative syndrome, because of its frequency and gravity, is most demanding of the physi cian's attention
  • 6. CASE • A 15 yr old male,came to ED with complaints of pain in the calf of the right leg on Tuesday(1week ago),followed by weakness of the both lower limbs the next day morning.was bed ridden after the onset of weakness.his bowel and bladder are intact.he is able to feel sensation of clothes over the lower limbs.he felt heaviness of the limbs..taken to local hospital was given treatment..where he noticed weakness in the upper limbs also. • no symptoms of cranial nerve involvement. • no hx fever at the onset of weakness. • no hx recent immunization or no h/o dog bite. • no hx seizures episodes. • no hx similar complaints in the past. • no hx similar complaints in the family.
  • 7. Clinical examination • Patient was consciuos coherent • no pallor ,icterus,clubbing,lymphadenopathy,edema. • His BP is 110/70 mm Hg in supine,100/70 mm Hg on standing.no postural hypotension. • Pulse -82/min regular,all peripheral pulses felt. • Respiratory rate -18 /min.breath holding time –able to count upto 45 in single breath.
  • 8. NERVOUS SYSTEM • Higher intellectual functions intact • Cranial nerves normal • Motor system showed hypotonia of all four limbs. • Grade 3/5 in upperlimbs,2/5 across the hip joint,knee joint,o/5 power across ankle joint. • Hyporeflexia all DTRs,absent ankle • Babinski negative,abdominal present • Sensory intact • Gait –stance … • Other systems normal.
  • 9. Key points • Rapid progressive ascending paralysis. • Acute onset • Motor paralysis • Intact sensory • No cranial nerve involvement • No bladder involvement • No fever at onset of weakness • Diagnosis………………??????????????????
  • 11. OTHER NAMES • LANDRY’S ASCENDING PARALYSIS • ACUTE INFLAMMATORY DEMYELINATING POLYNEUROPATHY (AIDP) • ACUTE IDIOPATHIC POLYRADICULONEURITIS • ACUTE IDIOPATHIC POLYNEURITIS • FRENCH POLIO • LANDRY GUILLAIN BARRE SYNDROME
  • 12. INTRODUCTION Acute,frequently severe and fulminant polyradiculoneuropathy that is autoimmune in nature.
  • 13. Antecedent events (causes) • 70% cases –post infectious . • 1-3 weeks after an acute infectious process respiratory or GIT. • 20-30% cases –campylobacter jejuni • Other agents –HHV (EBV,CMV) • Mycoplasma pneumoniae • Recent immunisation –swine influenza vaccine,older rabies vaccine (nervous system) • Can be seen in patients with lymphoma,HIV positive,SLE.
  • 14. AIDP • Adults > children • Rapid recovery • Anti GM1 ab (50%) • Demyelinating • First attack on schwann cell surface • Widespread myelin damage • Lymphocyte infiltration • Variable sec axonal damage
  • 16. AMAN (ACUTE MOTOR AXONAL NEUROPATHY) Acute motor axonal neuropathy (AMAN) is a variant of Guillain-Barré syndrome. It is characterized by acute paralysis and loss of reflexes without sensory loss. The syndrome typically presents as a progressive flaccid symmetric paralysis with areflexia, often causing respiratory failure • Children ,young adults • Seasonal • Recovery rapid • Anti GD1 a ab • Axonal • First attack on motor nodes of ranvier • Macrophage activation • Axonal damage is variable
  • 17. MILLER FISCHER VARIANT • Adults,children • Uncommon • Anti GQ 1 b anitbodies >90% (Not seen in other forms of GBS Unless there is EOM invovlement) • Pupillary paralysis
  • 18. Clinical manifestations FEVER AND CONSTITUTIONAL SYMPTOMS ARE ABSENT AT THE ONSET MOTOR SYSTEM : • Rapidly evolving areflexic motor paralysis with or without sensory disturbance. • Ascending type of paralysis • RUBBERY LEGS. • Weakness evolves over hours –days. • Legs>arms DEEPTENDON REFLEXES: Reflexes attenuate,disappear in few days of onset.
  • 20. CRANIAL NERVES: Facial diparesis seen in 50% affected individuals. Lower cranial nerves affected –bulbar weakness – difficulty in handling secretions,maintaining airway. Ophthalmoplegia –miller fischer variant Pupillary paralysis Optic atrophy
  • 21. SENSORY SYSTEM: Largely myelinated fibres are severely affected. Proprioception is more affected than pain temperature sensation. BLADDER: Only in severe cases,transiently. If bladder dysfunction is a prominent feature and comes early in the course,think other than GBS – spinal cord disease.
  • 22. • PAIN: • Deep aching pain may be present the previous day in weakened muscles. • Initially at onset –neck,shoulder,back,diffusely over spine -50% cases. • Dysesthetic pain in extremities • Self limited usually • Responds to analgesics
  • 23. • AUTONOMIC INVOLVEMENT: • Common • Seen even in mild cases • Wide fluctuation in blood pressure • Postural hypotension • Cardiac dysrryhthmias • Close monitoring and management • Can be fatal. • All require hospitalisation • 30% require ventilatory support
  • 24. course • Pattern of rapidly progressive (evolving) paralysis with areflexia • Usually does not progress beyond four weeks after reaching a plateau.
  • 25. Lab features CSF : • Raised CSF protein 1-10 g/l (100-1000mg/dl) • Without accompanied by pleocytosis • Usually normal in <1week • Increased proteins at the end of first week • 10-100/ul elevation • Think of HIV ,CMV in case of pleocytosis. ELECTRODIAGNOSTIC TESTS: May be normal Lags behind clinical events demyelination - prolonged distal latencies,conduction velocity slowing,condcution block. Reduced amplitude of compound action potential without conduction slowing
  • 26. Criteria for diagnosis REQUIRED : • 1.progressive weakness of 2 or more limbs due to neuropathy. • 2.areflexia • 3.disease course < 4 weeks • 4 exclusion of other causes (vasculitis,PAN,SLE,churg strauss syndrome,toxins,lead,botulism,diptheria,porphyria.,cauda equinal syndrome) SUPPORTIVE: • 1.relatively symmetric weakness • 2.mild sensory involvement • 3.facial nerve or other cranial nerve involvement • 4.absence of fever • 5.typical CSF profile(aceelualr,increase in protein level) • 6.electrophysiologic evidence of demyelination
  • 27. treatment • Initiate as soon as possible. • Each day counts • 2 weeks after the first motor symptoms – immunotherapy is no longer effective. • IVIg • Plasmapheresis • Combination is not effective • IVIg-first choice,easy to administer • Five daily infusions 2g/kg body weight • Plasmapheresis 40-50ml/kg four times a week • Treatment reduces need for ventilation by half.,increases full recovery at an year. • Glucocorticoids are not effective in GBS. • Conservative management in mild cases.
  • 28.  This type of polyneuropathy appears after several days or more of bacterial sepsis or other overwhelming infection (now called systemic inflammatory response syndrome [SIRS]) and multiple organ failure, and is preceded in most instances by a confusional state or a depressed state of consciousness ("septic encephalopathy").  The neuropathic process, predominantly of motor type, varies in severity from an electrophysiological abnormality without overt clinical signs, to quadriparesis with respiratory failure.  Sensory symptoms and signs are variable but tend to be mild. Usually the cranial nerves are spared and there are few or no dysautonomic manifestations. In general,  The EMG and NCS findings of a primary axonal process with early denervation and a normal CSF distinguish this entity from the typical demyelinative form of GBS. Critical Illness Polyneuropathy
  • 29. Local action of the exotoxin may paralyze pharyngeal and laryngeal muscles (dysphagia, nasal voice) within 1 or 2 weeks after the onset ofthe infection and shortly thereafter may cause blurring of vision because of paralysis of accommodation, but these and other cranial nerve symptoms may be overlooked. At this stage, the cranial neuropathy must be distinguished from that of GBS, botulism, and most of all, from myasthenia gravis. A polyneuropathy, appearing 5 to 8 weeks later, takes the form of an acute or subacute limb weakness with paresthesias and distal loss of vibratory and position sense. The weakness characteristically involves all extremities at the same time or may descend from arms to legs. The patient may be unable to stand or walk and occasionally the paralysis is so extensive as to impair respiration. The CSF protein is usually elevated (50 to 200 mg/dL) . The important pathologic change is one of segmental demyelination without inflammatory reaction of spinal roots, sensory ganglia, and adjacent spinal nerves.Anterior hom cells, axons, peripheral nerves Diphthertic Polyneuropathy
  • 30. • Treatment Diphtheria antitoxin, given within 48 h of the onset of the infection, Antitoxin is probably of little value once the polyneuropathy begins.Thereafter, treatment is purely symptomatic, along the lines indicated for GBS.
  • 31. Acute porphyria Acute porphyrias include forms of the disease that typically cause nervous system symptoms which appear quickly and can be life threatening. Acute porphyria attacks are rare be for puberty and after menopause in women. symptom may last one to two weeks and usually improve slowly after the attack.
  • 32. Possible sign and symptoms: severe abdominal pain swelling of the abdomen (abdominal distention) pain in your chest,legs or back constipation or diarrhea vomiting insomnia  heart beat you can feel (palpitation) high blood pressure anxiety or restlessness seizures mental change ,such as confusion,hallucination,disorientation or paranoia breathing problems muscle pain ,tingling,numbness,weakness or paralysis red or brown urine
  • 33. stopping medications that may have triggered symptoms medication to control pain,nausea and vomiting prompt treatment of infections or other illness that may have caused symptoms intravenous sugar(glucose) or sugar taken by mouth,if able maintain an adequate intake of carbohydrates intravenous fluids to combat dehydration injection of hemin,a medication that is a form of heme , to limit the body's production of porphyrin
  • 34. the peripheral nerves may be affected by a wide variety of toxins including metals, drugs, organophosphates, and industrial solvents. As a rule, the neuropathies induced by these agents fall into the subacute and chronic categories. However, certain drugs-notably triorthocresyl phosphate (TOCP) and other organophosphates , thallium and rarely, arsenic produce a polyneuropathy that may be fatal in a matter of days. Acute Toxic Polyneuropathies
  • 35. Severe and permanent motor paralysis is caused by TOCP; this ultimately proves to be a result of involvement of both upper and lower motor neurons. Some cases of arsenical and possibly mercurial polyneuropathy may also develop acutely.
  • 36. Thallium salts when taken in sufficient amount, produce a clinical picture resembling that of GBS or an acute sensory polyneuropathy. If the salts are taken orally,there is first abdominal pain, vomiting, and diarrhea, followed within a few days by pain and tingling in the toes and fingertips and then rapid weakening of muscles of the limbs, initially the distal ones. As the weakness progresses, the tendon reflexes diminish. Pain sensation is reduced more than tactile, vibratory; and position sense. Persistent acral pain with allodynia has been a major feature in 3 of the 5 patients we have examined; in 2 of our patients there was no weakness, only sensory loss and ataxia. All cranial nerves except the first and eighth may be affected; facial palsies, ophthalmoplegia, nystagmus, optic neuritis with visual impairment, and vocal cord palsies are additional abnormalities but only in the most severely affected patients. The CSF protein rises to more than 100 mg. Death may occur in the first 10 days as a result of cardiac arrest. The early onset of painful paresthesias, sensory loss, and pain localized to joints, back, and chest, as well as rapid loss of hair (after a week or two), all serve to differentiate this neuropathy from GBS,porphyria, and other acute polyneuropathies. Thallium salts act like potassium and a high intake of potassium chloride hastens the excretion of thallium. Chelating agents are of unproven value but are usually included in treatment.
  • 37. On occasion, a vasculitic polyneuropathy as an isolated process or associated with lupus erythematosus, polyarteritis nodosa, and related disorders may develop as rapidly as GBS. Three of our patients with polyarteritis and one with Churg-Strauss disease became completely paralyzed within a week and one died of intestinal perforation. We have observed a few patients with alcoholism,occult carcinoma, Hodgkin disease, and renal transplantation develop an acute polyneuropathy, as rapid in its evolution as GBS, and acute episodes of this type have also been described in patients with Refsum disease. Other Acute Polyneuropathies